M.G. Glaser

1.8k total citations
34 papers, 1.3k citations indexed

About

M.G. Glaser is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, M.G. Glaser has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Neurology. Recurrent topics in M.G. Glaser's work include Glioma Diagnosis and Treatment (12 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Brain Metastases and Treatment (5 papers). M.G. Glaser is often cited by papers focused on Glioma Diagnosis and Treatment (12 papers), CNS Lymphoma Diagnosis and Treatment (6 papers) and Brain Metastases and Treatment (5 papers). M.G. Glaser collaborates with scholars based in United Kingdom, Germany and United States. M.G. Glaser's co-authors include E.S. Newlands, Iain Colquhoun, Stephen R. Wedge, C. Brock, Mark Bower, Helen Evans, Paul D. Lewis, S.M. O'Reilly, R D Illingworth and Peter G. Richards and has published in prestigious journals such as New England Journal of Medicine, Cancer and British Journal of Cancer.

In The Last Decade

M.G. Glaser

34 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M.G. Glaser United Kingdom	15	775	444	379	316	296	34	1.3k
Stefano Pizzolitto Italy	23	309 0.4×	620 1.4×	161 0.4×	434 1.4×	216 0.7×	103	1.7k
William Mietlowski United States	16	695 0.9×	289 0.7×	99 0.3×	347 1.1×	170 0.6×	32	1.8k
L. S. Lashford United Kingdom	23	950 1.2×	388 0.9×	622 1.6×	687 2.2×	50 0.2×	47	1.9k
Markus Raderer Austria	20	212 0.3×	380 0.9×	328 0.9×	197 0.6×	296 1.0×	62	1.5k
Robert L. Krigel United States	17	189 0.2×	248 0.6×	191 0.5×	145 0.5×	293 1.0×	27	998
B. Maat Netherlands	12	523 0.7×	1.2k 2.7×	137 0.4×	177 0.6×	150 0.5×	21	2.1k
Erlinda Etcubanas United States	25	207 0.3×	1.0k 2.3×	319 0.8×	481 1.5×	455 1.5×	38	1.9k
Dirk Behringer Germany	27	321 0.4×	388 0.9×	112 0.3×	630 2.0×	145 0.5×	69	2.2k
O. Fernández Hidalgo Spain	8	970 1.3×	397 0.9×	110 0.3×	1.1k 3.6×	107 0.4×	16	1.9k
Ashish M. Ingle United States	24	383 0.5×	673 1.5×	815 2.2×	1.2k 3.9×	354 1.2×	36	2.5k

Countries citing papers authored by M.G. Glaser

Since Specialization

Citations

This map shows the geographic impact of M.G. Glaser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.G. Glaser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.G. Glaser more than expected).

Fields of papers citing papers by M.G. Glaser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.G. Glaser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.G. Glaser. The network helps show where M.G. Glaser may publish in the future.

Co-authorship network of co-authors of M.G. Glaser

This figure shows the co-authorship network connecting the top 25 collaborators of M.G. Glaser. A scholar is included among the top collaborators of M.G. Glaser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.G. Glaser. M.G. Glaser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Charnley, Natalie, Catharine West, Graeme M. Bydder, et al.. (2006). Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 66(2). 331–338. 30 indexed citations

Mead, Graham M., Norman M. Bleehen, Anna Gregor, et al.. (2000). A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma. Cancer. 89(6). 1359–1370. 129 indexed citations

Seckl, Michael J., Paul Mulholland, Anne E. Bishop, et al.. (1999). Hypoglycemia Due to an Insulin-Secreting Small-Cell Carcinoma of the Cervix. New England Journal of Medicine. 341(10). 733–736. 49 indexed citations

Botwood, N., et al.. (1999). Bilateral Cerebellopontine Metastases in a Patient with an Unknown Primary. Clinical Oncology. 11(4). 272–273. 4 indexed citations

Balesaria, Sara, C. Brock, Mark Bower, et al.. (1999). Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas. British Journal of Cancer. 81(8). 1371–1377. 54 indexed citations

Mead, G.M., NM Bleehen, A. Gregor, et al.. (1998). Medical Research Council (MRC) randomised trial of adjuvant chemotherapy in primary CNS lymphoma (PCL)- BR06.. UCL Discovery (University College London). 1 indexed citations

Brock, C., E.S. Newlands, Stephen R. Wedge, et al.. (1998). Phase I trial of temozolomide using an extended continuous oral schedule.. PubMed. 58(19). 4363–7. 228 indexed citations

Wedge, Stephen R., et al.. (1997). In vitro evaluation of temozolomide combined with X-irradiation. Anti-Cancer Drugs. 8(1). 92–97. 112 indexed citations

Leslie, Myles, et al.. (1993). Pneumothorax as a complication of tumour response to chemotherapy. Clinical Oncology. 5(3). 181–182. 4 indexed citations

10.

Leslie, Myles & M.G. Glaser. (1993). Impaired salivary gland function after radiotherapy compounded by commonly prescribed medications. Clinical Oncology. 5(5). 290–292. 4 indexed citations

11.

Russell, John, N. R. Bleach, M.G. Glaser, & A. D. Cheesman. (1993). Brachytherapy for recurrent nasopharyngeal and nasoethmoidal tumours. The Journal of Laryngology & Otology. 107(2). 115–120. 11 indexed citations

12.

O'Reilly, S.M., E.S. Newlands, M Brampton, et al.. (1993). Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours. European Journal of Cancer. 29(7). 940–942. 231 indexed citations

13.

Greinacher, Andreas, et al.. (1992). Heparin-associated thrombocytopenia: Successful therapy with the heparinoid Org 10172 in a patient showing cross-reaction to LMW heparins. Annals of Hematology. 64(1). 40–42. 21 indexed citations

14.

Daniels, David, C. Lowdell, & M.G. Glaser. (1992). The spontaneous regression of lymphoma in AIDS. Clinical Oncology. 4(3). 196–197. 3 indexed citations

15.

Glaser, M.G., et al.. (1990). Extradural metastases in a case of medulloblastoma. Clinical Oncology. 2(5). 295–297. 1 indexed citations

16.

Smith, David B., et al.. (1990). Quantitative distribution of 131I-labelled monoclonal antibodies administered by the intra-ventricular route. European Journal of Cancer and Clinical Oncology. 26(2). 129–136. 11 indexed citations

17.

Lowdell, C. & M.G. Glaser. (1989). Long Term Survival of Male Homosexual Patients with Kaposi's Sarcoma. Journal of the Royal Society of Medicine. 82(4). 226–227. 9 indexed citations

18.

Rustin, Gordon, Mary Minton, M.G. Glaser, et al.. (1987). Surgery, chemotherapy and whole abdominal radiotherapy in the management of advanced ovarian carcinoma. Clinical Radiology. 38(3). 269–272. 8 indexed citations

19.

Coburn, P. R., J J Cream, & M.G. Glaser. (1983). (19) Arsenical keratoses—response to etretinate and electron beam therapy. British Journal of Dermatology. 109(s24). 72–72. 25 indexed citations

20.

Glaser, M.G., et al.. (1979). A study of the effects of radiation on prevention of gynaecomastia due to oestrogen therapy.. PubMed. 5(3). 257–60. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact